This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Suresh Kumar Ponugupati: Innovator in Antiviral Compounds
Introduction
Suresh Kumar Ponugupati is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of antiviral research, particularly in the development of compounds targeting the Hepatitis C virus.
Latest Patents
Suresh Kumar Ponugupati holds 1 patent related to Hepatitis C virus inhibitors. His patent focuses on antiviral compounds that inhibit the function of the NS5A protein encoded by the Hepatitis C virus (HCV). The disclosure includes combinations of compounds, compositions comprising such combinations, and methods for inhibiting the NS5A protein's function.
Career Highlights
Suresh Kumar Ponugupati is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research in antiviral therapies. His work has the potential to impact the treatment of Hepatitis C significantly.
Collaborations
He has collaborated with notable colleagues, including Piyasena Hewawasam and Omar D. Lopez, contributing to a dynamic research environment focused on innovative solutions in healthcare.
Conclusion
Suresh Kumar Ponugupati's work in developing antiviral compounds showcases his commitment to addressing critical health challenges. His contributions to the field of Hepatitis C research are invaluable and highlight the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile